David Jackman, MD, is a Senior Physician in the Thoracic Oncology Program at the Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School. He received his undergraduate and medical degrees from Brown University, followed by his Internal Medicine residency at the Beth Israel Deaconess Medical Center in Boston, MA. After an oncology fellowship through the combined program at Dana-Farber and the Massachusetts General Hospital, he joined the thoracic group at DFCI.
His clinical research efforts have focused on targeted therapies in lung cancer and mesothelioma, as well as the clinical impact of predictive biomarkers for such therapies. Dr. Jackman is the Medical Director for the Dana-Farber Clinical Pathways program, a web-based, oncology decision-support platform powered by content wholly curated by Dana-Farber’s world class oncology faculty. Dr. Jackman is an author on over 50 peer-reviewed original research articles, as well as multiple reviews and book chapters.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)